Page last updated: 2024-10-26

3,3'-diindolylmethane and Osteosarcoma

3,3'-diindolylmethane has been researched along with Osteosarcoma in 1 studies

3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"The effect of the natural product 3,3'-diindolylmethane (DIM) on cytosolic Ca(2+) concentrations ([Ca(2+)](i)) and viability in MG63 human osteosarcoma cells was explored."7.783,3'-Diindolylmethane alters Ca2+ homeostasis and viability in MG63 human osteosarcoma cells. ( Chang, HT; Chen, IS; Chou, CT; Ho, CM; Hsu, SS; Huang, JK; Jan, CR; Kuo, CC; Liao, WC; Lin, KL; Liu, SI; Lu, YC; Tsai, JY; Wang, JL, 2012)
"The effect of the natural product 3,3'-diindolylmethane (DIM) on cytosolic Ca(2+) concentrations ([Ca(2+)](i)) and viability in MG63 human osteosarcoma cells was explored."3.783,3'-Diindolylmethane alters Ca2+ homeostasis and viability in MG63 human osteosarcoma cells. ( Chang, HT; Chen, IS; Chou, CT; Ho, CM; Hsu, SS; Huang, JK; Jan, CR; Kuo, CC; Liao, WC; Lin, KL; Liu, SI; Lu, YC; Tsai, JY; Wang, JL, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lu, YC1
Chen, IS1
Chou, CT1
Huang, JK1
Chang, HT1
Tsai, JY1
Hsu, SS1
Liao, WC1
Wang, JL1
Lin, KL1
Liu, SI1
Kuo, CC1
Ho, CM1
Jan, CR1

Other Studies

1 other study available for 3,3'-diindolylmethane and Osteosarcoma

ArticleYear
3,3'-Diindolylmethane alters Ca2+ homeostasis and viability in MG63 human osteosarcoma cells.
    Basic & clinical pharmacology & toxicology, 2012, Volume: 110, Issue:4

    Topics: Anticarcinogenic Agents; Apoptosis; Calcium; Calcium Channels; Cell Line, Tumor; Cell Survival; Dose

2012